Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Patient preferences have been shifting to subcutaneous delivery that enables at-home administration.
January 21, 2026
By: Patrick Lavery
Content Marketing Editor
Datwyler says it has developed a first-to-market universal plunger for large-volume cartridges containing up to 20mL. Adding to Datwyler’s line of NeoFlex fully coated plungers, it answers demand for on-body devices for subcutaneous biotherapeutics delivery.
According to Datwyler, biologics, which are seeing increased use, are predominantly delivered intravenously. This requires long visits to healthcare facilities. As such, at-home administration involving subcutaneous drug delivery is a growing patient preference.
However, challenges remain. These include limitations in formulation concentration and availability of standardized components, and complexity, cost, and time concerns in a competitive market.
Having a “pre-verified solution,” as Datwyler puts it, to overcome manufacturing hurdles can save companies up to three years in development time.
By offering a plunger for up to 20mL volumes, Datwyler says slow, controlled drug delivery across many devices is possible.
“We believe in innovating patient care through open collaboration,” said Paolo Ferrigno, Datwyler Product Manager, PFS & Cartridges. “So, we are proud to deliver the first-to-market universal, fully coated plunger in this size, helping our peers across pharmaceutical and medical device companies continue to improve the patient experience in receiving high-dose therapies.”
Datwyler’s announcement came the same day BD and Ypsomed announced they developed a 5.5ml version of a glass prefillable syringe. In that case, the companies said they were also responding to patient self-injection trends.
The Datwyler plunger features a non-fluorosurfactant grade fluoropolymer coating, ensuring a contact-safe surface, according to the company. This also prohibits exposure to extractables and leachables, among other contaminants.
Container closure integrity is maintained, Datwyler said, under demanding conditions. Additionally, consistent and minimal gliding forces enable accurate dosing.Manufacturing is done in cleanroom environments incorporating automated production cells and camera inspection, to ensure quality assurance and risk mitigation.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !